Latest News and Press Releases

PHILADELPHIA, Pennsylvania and COPENHAGEN, Denmark, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Alveus Therapeutics, Inc. (“Alveus”), a clinical-stage biotechnology company developing next-generation...

Torino, Italy, January 22 – Resalis Therapeutics, a biotechnology company pioneering microRNA-targeted therapies, today announced the appointment of Sandor Batkai, MD, PhD, as Medical Director. Dr....

Searches for "best colostrum supplement for weight loss" rise as consumers evaluate options like Cowboy Colostrum based on sourcing and IgG.

Financing supports Phase 2 development of ALV-100, IND filing of ALV-200 and advancement of additional programs across the R&D pipeline ALV-100, a bifunctional GIPR antagonist / GLP-1R agonist,...

Riyadh, Saudi Arabia, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Professor Svetlana Mojsov was announced this year's King Faisal Prize in Medicine laureate for her groundbreaking discoveries that are...

Cambridge, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- If you’re considering setting a goal to lose weight in 2026, there is good news: Generative artificial intelligence can help. MIT Sloan School of...

NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight health, today announced access to Novo Nordisk’s newly...

Industry analysis compares FDA-approved Wegovy pricing from $149 oral to Ro's $199 injectable as telehealth access expands for 2026.

Industry analysis examines herbal wellness patch ingredients and regulatory classification as GLP-1 alternative searches surge heading into 2026.

Industry analysis examines herbal wellness patch ingredients and regulatory classification as GLP-1 alternative searches surge heading into 2026.